Laekna Therapeutics
Developing new ground-breaking innovative therapies to treat cancer and liver diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€222—333m (Dealroom.co estimates May 2022.)
Shanghai Shanghai (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$18.5m | Series A | ||
| N/A | $27.5m | Series B | |
$61.0m | Series C | ||
* | $61.0m | Series D | |
* | N/A | $101m | IPO |
| Total Funding | €153m | ||
Recent News about Laekna Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.